Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a developer of computerized drug delivery instruments for painless and precise injections, has announced a conference call scheduled for Thursday, August 15th, 2024, at 8:30 AM Eastern Time. The call will discuss the company's financial results for the second quarter ended June 30, 2024, along with corporate progress and other developments.
Investors can access the call via telephone by dialing 888-506-0062 (U.S. toll-free) or +1 973-528-0011 (international) with the access code: 959238. A webcast will also be available. An audio replay will be accessible until August 29th, 2024, by dialing 877-481-4010 (U.S.) or +1 919-882-2331 (international) with the access code: 51045.
Milestone Scientific Inc. (NYSE:MLSS), un sviluppatore di strumenti per la somministrazione computerizzata di farmaci per iniezioni indolori e precise, ha annunciato una conferenza telefonica programmata per giovedì 15 agosto 2024, alle 8:30 AM ora orientale. La chiamata discuterà i risultati finanziari dell'azienda per il secondo trimestre conclusosi il 30 giugno 2024, insieme ai progressi aziendali e ad altri sviluppi.
Gli investitori possono accedere alla chiamata tramite telefono componendo 888-506-0062 (numero verde USA) o +1 973-528-0011 (internazionale) con il codice di accesso: 959238. Sarà disponibile anche una trasmissione in diretta. Una registrazione audio sarà accessibile fino al 29 agosto 2024, componendo 877-481-4010 (USA) o +1 919-882-2331 (internazionale) con il codice di accesso: 51045.
Milestone Scientific Inc. (NYSE:MLSS), un desarrollador de instrumentos informáticos para la administración de medicamentos mediante inyecciones indoloras y precisas, ha anunciado una conferencia telefónica programada para el jueves 15 de agosto de 2024, a las 8:30 AM hora del Este. La llamada discutirá los resultados financieros de la compañía para el segundo trimestre que finalizó el 30 de junio de 2024, junto con los avances corporativos y otros desarrollos.
Los inversores pueden acceder a la llamada por teléfono marcando 888-506-0062 (número gratuito en EE. UU.) o +1 973-528-0011 (internacional) con el código de acceso: 959238. También estará disponible una transmisión web. Una grabación de audio estará accesible hasta el 29 de agosto de 2024, marcando 877-481-4010 (EE. UU.) o +1 919-882-2331 (internacional) con el código de acceso: 51045.
Milestone Scientific Inc. (NYSE:MLSS)는 통증 없는 정확한 주사를 위한 컴퓨터화된 약물 전달 기기를 개발하는 회사로, 2024년 8월 15일 목요일 오전 8시 30분(동부 표준시)에 예정된 컨퍼런스 콜을 발표했습니다. 이 전화 회의에서는 2024년 6월 30일자로 종료된 2분기 재무 결과와 회사의 진행 상황 및 기타 개발 사항에 대해 논의할 것입니다.
투자자들은 888-506-0062(미국 무료전화) 또는 +1 973-528-0011(국제전화)로 전화하여 접속 코드 959238을 입력하여 전화를 통해 참여할 수 있습니다. 웹캐스트도 이용 가능합니다. 오디오 재생은 2024년 8월 29일까지 이용 가능하며, 877-481-4010(미국) 또는 +1 919-882-2331(국제전화)로 전화하여 접속 코드 51045를 입력하면 됩니다.
Milestone Scientific Inc. (NYSE:MLSS), un développeur d'instruments informatisés pour l'administration de médicaments par des injections indolores et précises, a annoncé une conférence téléphonique prévue pour le jeudi 15 août 2024, à 8h30 heure de l'Est. L'appel portera sur les résultats financiers de l'entreprise pour le deuxième trimestre clôturé le 30 juin 2024, ainsi que sur les progrès de l'entreprise et d'autres développements.
Les investisseurs peuvent accéder à l'appel par téléphone en composant le 888-506-0062 (numéro gratuit aux États-Unis) ou +1 973-528-0011 (international) avec le code d'accès : 959238. Un webinaire sera également disponible. Une rediffusion audio sera accessible jusqu'au 29 août 2024 en composant le 877-481-4010 (États-Unis) ou +1 919-882-2331 (international) avec le code d'accès : 51045.
Die Milestone Scientific Inc. (NYSE:MLSS), ein Entwickler von computerisierten Arzneimittelabgabegeräten für schmerzfreie und präzise Injektionen, hat eine Telefonkonferenz für Donnerstag, den 15. August 2024, um 8:30 Uhr Eastern Time angekündigt. In der Konferenz werden die Finanzergebnisse des Unternehmens für das im Juni 2024 endende zweite Quartal sowie Unternehmensfortschritte und weitere Entwicklungen besprochen.
Investoren können die Konferenz telefonisch unter 888-506-0062 (kostenlos in den USA) oder +1 973-528-0011 (international) erreichen, indem sie den Zugangscode: 959238 nutzen. Auch eine Webcast-Veranstaltung wird verfügbar sein. Eine Audio-Wiedergabe ist bis zum 29. August 2024 unter der Nummer 877-481-4010 (USA) oder +1 919-882-2331 (international) mit dem Zugangscode: 51045 zugänglich.
- None.
- None.
ROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, August 15th, 2024, to discuss the company’s financial results for the second quarter ended June 30, 2024, as well as the company’s corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 959238. A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster4.com/Webcast/Page/2306/51045.
An audio replay of the call will be available through Thursday, August 29th, 2024, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 51045.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS), a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.
Contact:
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020
FAQ
When is Milestone Scientific's Q2 2024 earnings call scheduled?
How can investors access Milestone Scientific's (MLSS) Q2 2024 earnings call?
What period will Milestone Scientific's (MLSS) upcoming earnings report cover?
Until when will the audio replay of Milestone Scientific's Q2 2024 earnings call be available?
